Mural Financial Statements From 2010 to 2025

MURA Stock   3.77  0.02  0.53%   
Mural Oncology financial statements provide useful quarterly and yearly information to potential Mural Oncology plc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Mural Oncology financial statements helps investors assess Mural Oncology's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Mural Oncology's valuation are summarized below:
Market Capitalization
64 M
Earnings Share
(9.03)
We have found one hundred six available fundamental ratios for Mural Oncology, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Mural Oncology last-minute market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. The current year's Enterprise Value is expected to grow to about (171.6 M)
Check Mural Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mural Oncology's main balance sheet or income statement drivers, such as Tax Provision of 14.7 M, Depreciation And Amortization of 2 M or Selling General Administrative of 26.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.35. Mural financial statements analysis is a perfect complement when working with Mural Oncology Valuation or Volatility modules.
  
Check out the analysis of Mural Oncology Correlation against competitors.

Mural Oncology Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets364.4 M347 M91.8 M
Slightly volatile
Short and Long Term Debt Total15.9 M13.5 M23 M
Slightly volatile
Other Current Liabilities17.8 M12.5 M12.4 M
Slightly volatile
Total Current Liabilities27.7 M26.1 M32.7 M
Slightly volatile
Property Plant And Equipment Net22.4 M21.7 M29.2 M
Slightly volatile
Accounts Payable5.2 M5.4 M9.2 M
Slightly volatile
Non Current Assets Total22.5 M22 M29.3 M
Slightly volatile
Common Stock Shares Outstanding18.4 M19.2 M16.9 M
Slightly volatile
Liabilities And Stockholders Equity364.4 M347 M91.8 M
Slightly volatile
Non Current Liabilities Total11.3 MM17.4 M
Slightly volatile
Capital Lease Obligations15.9 M13.5 M23 M
Slightly volatile
Other Current Assets801.1 K843.3 K3.6 M
Slightly volatile
Total Liabilities39 M34.1 M50.1 M
Slightly volatile
Property Plant And Equipment Gross47.7 M52 M59.1 M
Slightly volatile
Total Current Assets334.9 M318.9 M61.7 M
Slightly volatile
Non Current Liabilities Other264 K273.6 K338.6 K
Slightly volatile
Short Term Debt13.1 M14 M12.1 M
Slightly volatile
Non Currrent Assets Other206.4 K232.2 K253.2 K
Slightly volatile
Net Receivables4.4 MM5.4 M
Slightly volatile
Inventory120 K135 K147.2 K
Slightly volatile
Other Stockholder Equity235.6 M265.1 M289 M
Slightly volatile
Common Stock133.6 K150.3 K163.9 K
Slightly volatile

Mural Oncology Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision14.7 M14 M2.9 M
Slightly volatile
Depreciation And AmortizationMM1.7 M
Slightly volatile
Selling General Administrative26.2 M35.3 M19 M
Slightly volatile
Other Operating Expenses207.2 M223.8 M182.8 M
Slightly volatile
Research Development180.4 M186.3 M163.5 M
Slightly volatile
Cost Of RevenueMM1.7 M
Slightly volatile
Total Operating Expenses206.3 M220.9 M182.4 M
Slightly volatile
Reconciled DepreciationMM1.7 M
Slightly volatile
Income Tax Expense14.7 M14 M2.9 M
Slightly volatile
Selling And Marketing Expenses533.6 K600.3 K654.5 K
Slightly volatile

Mural Oncology Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation17.4 M27.7 M13.7 M
Slightly volatile
Other Cashflows From Financing Activities294.8 M539.1 M213.1 M
Slightly volatile
DepreciationMM1.7 M
Slightly volatile
Other Non Cash Items2.2 M2.3 M12.2 M
Slightly volatile
Capital Expenditures3.6 M3.1 M4.3 M
Slightly volatile
Total Cash From Financing Activities294.8 M539.1 M213.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation2.891.552.8164
Slightly volatile
Payables Turnover0.290.390.2062
Slightly volatile
Days Payables Outstanding1.5 K9772.2 K
Slightly volatile
Income Quality0.730.840.8819
Slightly volatile
Current Ratio9.038.61.8021
Slightly volatile
Graham Number62.8359.8424.9308
Slightly volatile
Capex Per Share0.30.240.2644
Very volatile
Interest Debt Per Share1.311.031.4124
Slightly volatile
Debt To Assets0.05430.05720.5866
Slightly volatile
Days Of Payables Outstanding1.5 K9772.2 K
Slightly volatile
Ebt Per Ebit0.80.90.9842
Slightly volatile
Quick Ratio9.038.61.8021
Slightly volatile
Net Income Per E B T0.820.960.992
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.171.0429
Slightly volatile
Debt Ratio0.05430.05720.5866
Slightly volatile

Mural Oncology Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap60.2 M88.9 M67 M
Slightly volatile

Mural Fundamental Market Drivers

Cash And Short Term Investments270.9 M

Mural Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Mural Oncology Financial Statements

Mural Oncology stakeholders use historical fundamental indicators, such as Mural Oncology's revenue or net income, to determine how well the company is positioned to perform in the future. Although Mural Oncology investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mural Oncology's assets and liabilities are reflected in the revenues and expenses on Mural Oncology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mural Oncology plc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of RevenueMM

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Mural Oncology plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mural Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mural Oncology Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mural Oncology Plc Stock:
Check out the analysis of Mural Oncology Correlation against competitors.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mural Oncology. If investors know Mural will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mural Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.03)
Return On Assets
(0.81)
Return On Equity
(1.78)
The market value of Mural Oncology plc is measured differently than its book value, which is the value of Mural that is recorded on the company's balance sheet. Investors also form their own opinion of Mural Oncology's value that differs from its market value or its book value, called intrinsic value, which is Mural Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mural Oncology's market value can be influenced by many factors that don't directly affect Mural Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mural Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mural Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mural Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.